Seres Therapeutics, Inc.
MCRB
$9.31
-$0.77-7.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 136.00K | -25.48M | -162.11M | -82.68M | -113.72M |
| Total Depreciation and Amortization | 14.67M | 14.92M | 15.20M | 15.30M | 15.14M |
| Total Amortization of Deferred Charges | 1.41M | 1.82M | 1.75M | 1.42M | 1.14M |
| Total Other Non-Cash Items | -99.32M | -97.72M | 27.32M | 38.75M | 39.07M |
| Change in Net Operating Assets | -65.51M | -50.77M | -63.97M | -48.79M | -58.98M |
| Cash from Operations | -148.61M | -157.23M | -181.80M | -76.01M | -117.35M |
| Capital Expenditure | -380.00K | -1.17M | -2.84M | -3.97M | -7.98M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 141.27M | 141.27M | -- | -- | -- |
| Other Investing Activities | 1.40M | 1.40M | 1.40M | 11.75M | 18.56M |
| Cash from Investing | 142.29M | 141.51M | -1.43M | 7.78M | 10.58M |
| Total Debt Issued | -- | 0.00 | 0.00 | 103.38M | 103.38M |
| Total Debt Repaid | -127.91M | -127.91M | 0.00 | -52.86M | -52.86M |
| Issuance of Common Stock | 37.53M | 42.23M | 26.63M | 34.29M | 21.19M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -90.37M | -85.68M | 26.63M | 84.81M | 71.71M |
| Foreign Exchange rate Adjustments | -1.00K | 0.00 | 1.00K | 2.00K | 2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.69M | -101.40M | -156.60M | 16.59M | -35.07M |